ADAG

Adagene Inc.

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Sarepta Therapeutics (SRPT) and Adagene (ADAG)

• Dow Jones·1d ago

  Adagene Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

• Benzinga·1d ago

  HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $7 Price Target

• TipRanks·09/29 10:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)

• TipRanks·09/25 21:01

  Adagene Announces Finance Executive Resignation Effective September 30, 2026

• NASDAQ·09/22 20:21

  Adagene Gains NMPA Clearance On Phase 1 For ADG138 In Solid Tumors, Set To Begin In Q4 '26

• TipRanks·09/22 12:27

  Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

• TipRanks·09/22 12:05

  Adagene announces China’s NMPA approved IND for ADG138

• Benzinga·09/22 12:01

  China’s NMPA Approves Adagene’s IND Application For ADG138, Double-Masked HER2×CD3 Bispecific T Cell Engager Built On Proprietary SAFEbody Precision Masking Technology

• TipRanks·09/18 02:05

  Adagene CEO Makes Bold Insider Move With Fresh Stock Purchase

• TipRanks·09/14 10:31

  Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Adagene (ADAG) and Medtronic (MDT)

• TipRanks·09/11 11:40

  Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

• TipRanks·09/10 15:05

  Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8

• TipRanks·09/10 12:28

  Adagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected

• Benzinga·09/10 12:07

  Third Arc Bio Selects First Lead Candidate Upon 2025 Amended Strategic License Deal With Adagene